The effect of omalizumab on blood eosinophils count in patients with hypersensitivity to non-steroidal anti-inflammatory drugs (NSAID) compare to patients who tolerate NSAID–pilot study

I. Kuprys-Lipinska (Lodz, Poland), L. Mastalerz (Cracow, Poland), P. Majak (Lodz, Poland), K. Tyrak (Cracow, Poland), J. Molinska (Lodz, Poland), M. Jonakowski (Lodz, Poland), Z. Kurmanowska (Lodz, Poland), M. Latek (Lodz, Poland), D. Krzyzanowski (Lodz, Poland), A. Zal (Lodz, Poland), P. Kuna (Lodz, Poland)

Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session: Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Session type: Thematic Poster
Number: 1128
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Kuprys-Lipinska (Lodz, Poland), L. Mastalerz (Cracow, Poland), P. Majak (Lodz, Poland), K. Tyrak (Cracow, Poland), J. Molinska (Lodz, Poland), M. Jonakowski (Lodz, Poland), Z. Kurmanowska (Lodz, Poland), M. Latek (Lodz, Poland), D. Krzyzanowski (Lodz, Poland), A. Zal (Lodz, Poland), P. Kuna (Lodz, Poland). The effect of omalizumab on blood eosinophils count in patients with hypersensitivity to non-steroidal anti-inflammatory drugs (NSAID) compare to patients who tolerate NSAID–pilot study. 1128

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: